scispace - formally typeset
Open AccessJournal ArticleDOI

Antibodies to the β-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood

TLDR
Antibodies to the Alzheimer disease β‐amyloid peptide were used to identify βAP precursor fragments in blood and these data are significant for efforts to develop immunochemical assays to diagnose and monitor the progression of AD.
About
This article is published in FEBS Letters.The article was published on 1990-05-07 and is currently open access. It has received 39 citations till now. The article focuses on the topics: Epitope & Fibrinogen.

read more

Citations
More filters
Journal ArticleDOI

Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease

TL;DR: M measurement of plasma Abeta40 levels is not useful to support the clinical diagnosis of AD, and lower levels of CSF Abeta42 in the AD group are consistent with previous studies.
Patent

Prevention and treatment of amyloidogenic disease

TL;DR: In this article, the authors provide compositions and methods for treatment of amyloidogenic diseases, such as Alzheimer's disease, which entail administering an agent that induces a beneficial immune response against an Amyloid deposit in the patient.
Patent

Humanized antibodies that recognize beta amyloid peptide

TL;DR: In this article, the authors presented improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, including humanized antibodies.
Journal ArticleDOI

Amyloid β protein in plasma from patients with sporadic Alzheimer's disease

TL;DR: The unlikelihood that plasma Aβ assays would be useful as a diagnostic tool for Alzheimer's disease is suggested.
Journal Article

Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

TL;DR: Immunoelectron microscopy revealed that nonfibrillar Abeta immunoreactivity was located within lipofuscin-like granules in somewhat swollen astrocytes, raising the possibility that astroCytes take up Abeta and attempt to degrade it in lysosomes in the aged brain.
References
More filters
Journal ArticleDOI

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

TL;DR: A purified protein derived from the twisted beta-pleated sheet fibrils in cerebrovascular amyloidosis associated with Alzheimer's disease has been isolated and Amino acid sequence analysis and a computer search reveals this protein to have no homology with any protein sequenced thus far.
Journal ArticleDOI

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

TL;DR: An apparently full-length complementary DNA clone coding for the A4 polypeptide is isolated and sequenced and suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Journal ArticleDOI

Amyloid plaque core protein in Alzheimer disease and Down syndrome

TL;DR: The shared 4-kDa subunit indicates a common origin for the amyloids of the plaque core and of the congophilic angiopathy of Alzheimer disease and Down syndrome.
Journal ArticleDOI

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

TL;DR: It is suggested that protease inhibition by the longer APP(s) could be related to aberrant APP catabolism, and a cDNA library of a human glioblastoma cell line is isolated, together with a new cDNA which contains a 225-nucleotide insert.
Journal ArticleDOI

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

TL;DR: In this paper, the authors used complementary DNA libraries constructed from peripheral tissues to determine whether the messenger RNA encoding APP in these tissues is identical to that expressed in brain, and identified a second APP mRNA that encodes an additional internal domain with a sequence characteristic of a Kunitz-type serine protease inhibitor.
Related Papers (5)